<?xml version="1.0" encoding="UTF-8"?>
<p>In some disorders such as gastrointestinal tract inflammatory diseases, like Chronâ€™s disease, the colonization by 
 <italic>Candida</italic> spp. is promoted leading to an exacerbated production of inflammatory cytokines which further worsens the inflammatory condition [
 <xref rid="B16-antibiotics-10-00592" ref-type="bibr">16</xref>]. This triggers an endless circle of infection-inflammation that is generally controlled by the use of anti-inflammatory drugs. Nevertheless, these drugs have several side effects, including gastrointestinal, cardiovascular, hepatic, renal, cerebral and pulmonary complications [
 <xref rid="B17-antibiotics-10-00592" ref-type="bibr">17</xref>]. Therefore, the development of new antifungal and anti-inflammatory agents with less side effects is mandatory and compounds showing concomitantly both properties represent a valuable therapeutic strategy.
</p>
